22802095|t|The MAPT H1 haplotype is associated with tangle-predominant dementia.
22802095|a|Tangle-predominant dementia (TPD) patients exhibit cognitive decline that is clinically similar to early to moderate-stage Alzheimer disease (AD), yet autopsy reveals neurofibrillary tangles in the medial temporal lobe composed of the microtubule-associated protein tau without significant amyloid-beta (Abeta)-positive plaques. We performed a series of neuropathological, biochemical and genetic studies using autopsy brain tissue drawn from a cohort of 34 TPD, 50 AD and 56 control subjects to identify molecular and genetic signatures of this entity. Biochemical analysis demonstrates a similar tau protein isoform composition in TPD and AD, which is compatible with previous histological and ultrastructural studies. Further, biochemical analysis fails to uncover elevation of soluble Abeta in TPD frontal cortex and hippocampus compared to control subjects, demonstrating that non-plaque-associated Abeta is not a contributing factor. Unexpectedly, we also observed high levels of secretory amyloid precursor protein alpha (sAPPalpha) in the frontal cortex of some TPD patients compared to AD and control subjects, suggesting differences in APP processing. Finally, we tested whether TPD is associated with changes in the tau gene (MAPT). Haplotype analysis demonstrates a strong association between TPD and the MAPT H1 haplotype, a genomic inversion associated with some tauopathies and Parkinson disease (PD), when compared to age-matched control subjects with mild degenerative changes, i.e., successful cerebral aging. Next-generation resequencing of MAPT followed by association analysis shows an association between TPD and two polymorphisms in the MAPT 3' untranslated region (UTR). These results support the hypothesis that haplotype-specific variation in the MAPT 3' UTR underlies an Abeta-independent mechanism for neurodegeneration in TPD.
22802095	4	8	MAPT	Gene	4137
22802095	41	68	tangle-predominant dementia	Disease	MESH:D003704
22802095	70	97	Tangle-predominant dementia	Disease	MESH:D003704
22802095	99	102	TPD	Disease	MESH:D003704
22802095	104	112	patients	Species	9606
22802095	121	138	cognitive decline	Disease	MESH:D003072
22802095	193	210	Alzheimer disease	Disease	MESH:D000544
22802095	212	214	AD	Disease	MESH:D000544
22802095	237	260	neurofibrillary tangles	Disease	MESH:D055956
22802095	305	335	microtubule-associated protein	Gene	51115
22802095	336	339	tau	Gene	4137
22802095	360	372	amyloid-beta	Gene	351
22802095	374	379	Abeta	Gene	351
22802095	528	531	TPD	Disease	MESH:D003704
22802095	536	538	AD	Disease	MESH:D000544
22802095	668	671	tau	Gene	4137
22802095	703	706	TPD	Disease	MESH:D003704
22802095	711	713	AD	Disease	MESH:D000544
22802095	859	864	Abeta	Gene	351
22802095	868	871	TPD	Disease	MESH:D003704
22802095	974	979	Abeta	Gene	351
22802095	1140	1143	TPD	Disease	MESH:D003704
22802095	1144	1152	patients	Species	9606
22802095	1165	1167	AD	Disease	MESH:D000544
22802095	1259	1262	TPD	Disease	MESH:D003704
22802095	1297	1300	tau	Gene	4137
22802095	1307	1311	MAPT	Gene	4137
22802095	1375	1378	TPD	Disease	MESH:D003704
22802095	1387	1391	MAPT	Gene	4137
22802095	1447	1458	tauopathies	Disease	MESH:D024801
22802095	1463	1480	Parkinson disease	Disease	MESH:D010300
22802095	1482	1484	PD	Disease	MESH:D010300
22802095	1630	1634	MAPT	Gene	4137
22802095	1697	1700	TPD	Disease	MESH:D003704
22802095	1730	1734	MAPT	Gene	4137
22802095	1843	1847	MAPT	Gene	4137
22802095	1868	1873	Abeta	Gene	351
22802095	1900	1917	neurodegeneration	Disease	MESH:D019636
22802095	1921	1924	TPD	Disease	MESH:D003704
22802095	Association	MESH:D003704	4137
22802095	Association	MESH:D019636	4137
22802095	Association	MESH:D010300	4137
22802095	Association	MESH:D024801	4137

